This protocol is judged by an institutional critique board, an impartial group that reviews any clinical trials involving individuals. If a examine requires a Timetable I drug, when the board approves the protocol as moral, the researchers have to submit an application for an investigational new drug (IND) quantity within the FDA.Clients reported